Literature DB >> 17939754

High yield expression of serine/threonine protein phosphatase type 5, and a fluorescent assay suitable for use in the detection of catalytic inhibitors.

Li Ni1, Mark S Swingle, Austin C Bourgeois, Richard E Honkanen.   

Abstract

Protein phosphatase type 5 (PP5) belongs to the PPP family of serine/threonine protein phosphatases and is expressed in most, if not all, human tissues. Although the physiological roles played by PP5 are not yet clear, PP5 is found in association with several proteins that influence intracellular signaling networks initiated by hormones (i.e., glucocorticoids) or cellular stress (i.e., hypoxia, oxidative stress). Recently, studies conducted with short interfering RNA and antisense oligonucleotides indicate that PP5 plays an important role in the regulation of stress-induced signaling cascades that influence both cell growth and the onset of apoptosis. Therefore, the identification of small molecule inhibitors of PP5 is desired for use in studies to further define the biological/pathological roles of PP5. Such inhibitors may also prove useful for development into novel antitumor agents. Here we describe methods to express and purify large amounts of biologically active PP5c, an inhibitor titration-based assay to determine the amount of PP5 in solution, and a fluorescent phosphatase assay that can be used to screen chemical libraries and natural extracts for the presence of catalytic inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17939754      PMCID: PMC2493290          DOI: 10.1089/adt.2007.079

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  28 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Rac GTPase signaling through the PP5 protein phosphatase.

Authors:  Saverio Gentile; Thomas Darden; Christian Erxleben; Charles Romeo; Angela Russo; Negin Martin; Sandra Rossie; David L Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

3.  The tetratricopeptide repeat domain of protein phosphatase 5 mediates binding to glucocorticoid receptor heterocomplexes and acts as a dominant negative mutant.

Authors:  M S Chen; A M Silverstein; W B Pratt; M Chinkers
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

4.  Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress.

Authors:  K Morita; M Saitoh; K Tobiume; H Matsuura; S Enomoto; H Nishitoh; H Ichijo
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

5.  Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade.

Authors:  Guofei Zhou; Teresa Golden; Ileana V Aragon; Richard E Honkanen
Journal:  J Biol Chem       Date:  2004-08-24       Impact factor: 5.157

6.  Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A.

Authors:  R E Honkanen
Journal:  FEBS Lett       Date:  1993-09-20       Impact factor: 4.124

7.  Identification of a functional link for the p53 tumor suppressor protein in dexamethasone-induced growth suppression.

Authors:  Gudrun Urban; Teresa Golden; Ileana V Aragon; Lex Cowsert; Scott R Cooper; Nicholas M Dean; Richard E Honkanen
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

Review 8.  Galpha12 and Galpha13 as key regulatory mediator in signal transduction.

Authors:  Hitoshi Kurose
Journal:  Life Sci       Date:  2003-12-05       Impact factor: 5.037

9.  Structural basis for the catalytic activity of human serine/threonine protein phosphatase-5.

Authors:  Mark R Swingle; Richard E Honkanen; Ewa M Ciszak
Journal:  J Biol Chem       Date:  2004-05-23       Impact factor: 5.157

10.  Molecular recognition via coupled folding and binding in a TPR domain.

Authors:  Matthew J Cliff; Mark A Williams; John Brooke-Smith; David Barford; John E Ladbury
Journal:  J Mol Biol       Date:  2005-01-18       Impact factor: 5.469

View more
  12 in total

1.  The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C.

Authors:  Brandon M D'Arcy; Mark R Swingle; Cinta M Papke; Kevin A Abney; Erin S Bouska; Aishwarya Prakash; Richard E Honkanen
Journal:  Mol Cancer Ther       Date:  2019-01-24       Impact factor: 6.261

2.  G protein-coupled receptors (GPCRs) That Signal via Protein Kinase A (PKA) Cross-talk at Insulin Receptor Substrate 1 (IRS1) to Activate the phosphatidylinositol 3-kinase (PI3K)/AKT Pathway.

Authors:  Nathan C Law; Morris F White; Mary E Hunzicker-Dunn
Journal:  J Biol Chem       Date:  2016-11-17       Impact factor: 5.157

3.  Development and validation of a robust and sensitive assay for the discovery of selective inhibitors for serine/threonine protein phosphatases PP1α (PPP1C) and PP5 (PPP5C).

Authors:  Mark R Swingle; Richard E Honkanen
Journal:  Assay Drug Dev Technol       Date:  2014-10       Impact factor: 1.738

4.  Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-γ (PPARγ).

Authors:  Terry D Hinds; Lance A Stechschulte; Harrison A Cash; Donald Whisler; Ananya Banerjee; Weidong Yong; Saja S Khuder; Meenakshi K Kaw; Weinian Shou; Sonia M Najjar; Edwin R Sanchez
Journal:  J Biol Chem       Date:  2011-10-12       Impact factor: 5.157

5.  Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity.

Authors:  Xiulan Yang; Yanping Liu; Xi-Ming Yang; Fangdi Hu; Lin Cui; Mark R Swingle; Richard E Honkanen; Peyman Soltani; Renaud Tissier; Michael V Cohen; James M Downey
Journal:  Basic Res Cardiol       Date:  2011-03-12       Impact factor: 17.165

6.  Deprotonation states of the two active site water molecules regulate the binding of protein phosphatase 5 with its substrate: A molecular dynamics study.

Authors:  Lingyun Wang; Feng Yan
Journal:  Protein Sci       Date:  2017-07-28       Impact factor: 6.725

7.  Activated Rac1 GTPase translocates protein phosphatase 5 to the cell membrane and stimulates phosphatase activity in vitro.

Authors:  Anindya Chatterjee; Ling Wang; David L Armstrong; Sandra Rossie
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

8.  Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C.

Authors:  Debasish Chattopadhyay; Mark R Swingle; Edward A Salter; Eric Wood; Brandon D'Arcy; Catherine Zivanov; Kevin Abney; Alla Musiyenko; Scott F Rusin; Arminja Kettenbach; Larry Yet; Chad E Schroeder; Jennifer E Golden; Wade H Dunham; Anne-Claude Gingras; Surajit Banerjee; David Forbes; Andrzej Wierzbicki; Richard E Honkanen
Journal:  Biochem Pharmacol       Date:  2016-03-23       Impact factor: 5.858

9.  Small G proteins Rac1 and Ras regulate serine/threonine protein phosphatase 5 (PP5)·extracellular signal-regulated kinase (ERK) complexes involved in the feedback regulation of Raf1.

Authors:  Matthew D Mazalouskas; Raquel Godoy-Ruiz; David J Weber; Danna B Zimmer; Richard E Honkanen; Brian E Wadzinski
Journal:  J Biol Chem       Date:  2013-12-26       Impact factor: 5.157

10.  Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth.

Authors:  Leia C Shuhaibar; Nabil Kaci; Jeremy R Egbert; Thibault Horville; Léa Loisay; Giulia Vigone; Tracy F Uliasz; Emilie Dambroise; Mark R Swingle; Richard E Honkanen; Martin Biosse Duplan; Laurinda A Jaffe; Laurence Legeai-Mallet
Journal:  JCI Insight       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.